Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS study.

Autor: Ishii, Tomonori, Kunishige, Hideaki, Kobayashi, Tamami, Hayashi, Etsuko, Komatsubara, Masaki, Ishii, Takeo, Alfonso-Cristancho, Rafael, Tamaoki, Jun, Howarth, Peter

Publikováno v: Modern Rheumatology; Sep2024, Vol. 34 Issue 5, p978-987, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

One-Step Stereocontrol of Three Contiguous Stereogenic Centers in Acyclic Systems: The Tuning Effect of an Additive in a Tandem Asymmetric Michael Addition and Meerwein–Ponndorf–Verley Reduction We are grateful to the Ministry of Education, Culture, Sports, Science, and Technology of Japan for partial support of this research [Grant-in-Aid for Scientific Research (B) (13470474)]. P.K.P. acknowledges the JSPS for a postdoctoral fellowship.

Autor: Nishide, Kiyoharu, Ozeki, Minoru, Kunishige, Hideaki, Shigeta, Yukihiro, Patra, Pranab K., Hagimoto, Yuri, Node, Manabu

Publikováno v: Angewandte Chemie. International Edition; September 29, 2003, Vol. 42 Issue: 37 p4515-4517, 3p

One-Step Stereocontrol of Three Contiguous Stereogenic Centers in Acyclic Systems: The Tuning Effect of an Additive in a Tandem Asymmetric Michael Addition and Meerwein-Ponndorf-Verley Reduction.

Autor: Nishide, Kiyoharu, Ozeki, Minoru, Kunishige, Hideaki, Shigeta, Yukihiro, Patra, Pranab K., Hagimoto, Yuri, Node, Manabu

Publikováno v: ChemInform; Jan2004, Vol. 35 Issue 3, pno-no, 1p

Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: long-term observation of the MARS study.

Autor: Ishii T; Tohoku University Hospital, Clinical Research Innovation and Education Centre, Sendai, Japan.; Tohoku Medical and Pharmaceutical University, Division of Hematology and Rheumatology, Sendai, Japan., Kunishige H; Value Evidence & Outcomes, GSK, Tokyo, Japan., Kobayashi T; Clinical Statistics, GSK, Tokyo, Japan., Hayashi E; Respiratory/Immunology Medical Affairs, GSK, Tokyo, Japan., Komatsubara M; Value Evidence & Outcomes, GSK, Tokyo, Japan., Alfonso-Cristancho R; Value Evidence & Outcomes, GSK, Collegeville, PA, USA., Tamaoki J; Tokyo Women's Medical University, Tokyo, Japan., Howarth P; Global Medical Affairs, GSK, London, UK.

Publikováno v: Modern rheumatology [Mod Rheumatol] 2024 Nov 07. Date of Electronic Publication: 2024 Nov 07.